Etteplan’s continued good performance in Q1 was overshadowed by significant non-recurring items.
Marimekko reports its Q1 result on Tuesday, May 16th.
Båttillverkaren står en tuffare marknad till mötes men värderingen och förväntningarna är låga.
Solid project portfolio of ~24.5 GW We lower '23e EBIT by 14%, '24-'25e roughly unchanged The share ...
Aptahem har publicerat bolagets rapport för första kvartalet 2023 och visar på fortsatta framsteg.
Redeye comments on Fragbite Groups Q1’23 report, where net sales came in stronger than expected whil...
Redeye leaves its comments on Acarix following the company’s Q1 2023 report.
Overhead costs too large for current operations Needs an acquisition to grow into the opex base, or ...
Redeye thinks the worst quarter has now passed and that the remainder of 2023 looks brighter, especi...
Redeye updates its estimates and base case following Tessin’s Q1 report which showed better-than-exp...
With better-than-expected performance in RoW, partly owing to Casumba and the Japanese market, Raket...
2023e sales and earnings forecasts lowered by 2-13% Danish operations performing well under current ...
Awaiting the environmental court's response Viscaria estimated full run-rate EBITDA of SEK 1.
Scandinavian Astor Group (”Astor Group” eller ”bolaget”) publicerade den 11 maj år 2023 bolagets del...
Redeye comments on the outcome of Hoylu’s rights issue announced yesterday evening.
Smart High Tech publicerade den 11 maj 2023 bolagets delårsrapport för det första kvartalet 2023.
Watch the replay from InDex Pharmaceuticals' business update on May 9.
Carlsquare Equity Research kommenterar delårsrapporten och de senaste nyheterna rörande Aberas proje...
ChargePanel publicerade den 11 maj år 2023 bolagets delårsrapport för det första kvartalet 2023.
Redeye notes a higher OPEX than expected in the company’s Q1 report.
